Can umbilical cord stem cells reverse frailty in the elderly?
Disease control
Not yet recruiting
This early-stage trial tests the safety of an experimental stem cell product called MiraMSC in people aged 60 to 85 with mild to moderate frailty. MiraMSC is made from donated umbilical cord stem cells and is given through an IV. The study will look at different dose schedules to…
Phase: PHASE1 • Sponsor: Miracle Biomedical Co., Ltd. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC